problems with glp 1 drugs GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity GLP-1 and Shortness of Breath:

Liraglutide-induced acute pancreatitis

Having a gastroenterologist involved is particularly relevant given that digestive side effects are among the most common complaints from GLP-1 users

Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia

Furthermore, mitochondrial dysfunction combined with inflammation increases the number of metabolic complications and the risk of CVD [123,124]

Collectively, such findings are remarkable in that they suggest a new strategy in which the co-existing metabolic disorders of type 2 diabetes and obesity will be treatable using a single peptide such as EP45 that lowers levels of blood glucose by virtue of its GLP-1R-mediated effect, while simultaneously suppressing appetite by virtue of its NPY2R-mediated effect

Side Effects: Common Side Effects: Nausea, vomiting, diarrhoea, constipation and abdominal discomfort are common, particularly in the early weeks and after each dose increase